BEIJING, Dec. 30 (Xinhua) — The following is a summary of published science and technology news of China.
ORAL COVID-19 DRUG
An oral antiviral agent called VV116, which is a potent anti-COVID-19 drug, is just as effective as Paxlovid in increasing the speed of clinical recovery, according to a scientific study published on Wednesday in the New England Journal of Medicine.
The China-developed anti-coronavirus drug has shown improved performance during the early onset of Omicron infections. Its developers include several institutes under the Chinese Academy of Sciences.
SPACE EXPERIMENT SATELLITE
China on Thursday launched a Long March-3B carrier rocket, using it to place a new experiment satellite in space.
The rocket blasted off at 12:43 p.m. (Beijing Time) from the Xichang Satellite Launch Center in southwest China and carried the Shiyan-10 02 satellite to a preset orbit.
CHINA’S SCIENTIFIC PAPERS
China produced a total of 480,500 scientific papers classified as “excellent” in 2021, an increase of about 17,000 over the previous year, an official report showed Thursday.
Among the papers, some 211,300 were published in international journals, according to the report released by the Institute of Scientific and Technical Information under the Ministry of Science and Technology.
The report defines excellent scientific papers as those published in international and domestic scientific journals with high-impact factors and citations. Enditem
